Maitland-van der Zee, Anke-Hilse <br/><br/>
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study.  [electronic resource] 

 -  Pharmacogenetics and genomics  May 2009 
 - 338-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1744-6872 
<br/><br/><label>Standard No.: </label>10.1097/fpc.0b013e32832933b7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Coagulation Factors--genetics<br/>Coronary Disease--etiology<br/>Drug Resistance--genetics<br/>Female<br/>Genetic Predisposition to Disease<br/>Genotype<br/>Humans<br/>Hypertension--complications<br/>Hypolipidemic Agents--therapeutic use<br/>Linkage Disequilibrium<br/>Male<br/>Middle Aged<br/>Polymorphism, Single Nucleotide--physiology<br/>Pravastatin--therapeutic use<br/>Treatment Outcome